Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
AMBALALSA

Ambalal Sarabhai Enterprises Share Price

 

 

Ambalal Sarabhai Enterprises live price: ₹30.8. It opened at ₹32 vs previous close ₹31; intraday high/low: ₹32/₹31. The 50 & 200 DMA stand at ₹29.81/₹31.16.

Ambalal Sarabhai Enterprises Performance

  • Today's Low
  • ₹31
  • Today's High
  • ₹32
  • 52 Week Low
  • ₹30
  • 52 Week High
  • ₹36
  • Open Price₹32
  • Previous Close₹31
  • Volume21,786
  • 50 DMA₹29.81
  • 100 DMA₹29.33
  • 200 DMA₹31.16

Ambalal Sarabhai Enterprises Chart

Investment Returns

  • Over 1 Month + 7.47%
  • Over 3 Month + 7.77%
  • Over 6 Month -2.1%
  • Over 1 Year -16.8%

Smart Investing Starts Here Start SIP with Ambalal Sarabhai Enterprises for Steady Growth!

Invest Now

Ambalal Sarabhai Enterprises Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.4
  • PEG Ratio
  • -1
  • Market Cap Cr
  • 236
  • P/B Ratio
  • 1.6
  • Average True Range
  • 2.02
  • EPS
  • 2.31
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.1
  • RSI
  • 50.57
  • MFI
  • 57.63

Ambalal Sarabhai Enterprises Financials

Ambalal Sarabhai Enterprises Technicals

EMA & SMA

Current Price
₹30.80
-0.18 (-0.58%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹31.35
  • 50 Day
  • ₹29.81
  • 100 Day
  • ₹29.33
  • 200 Day
  • ₹31.16

Resistance and Support

31.07 Pivot Speed
  • R3 32.19
  • R2 31.83
  • R1 31.43
  • S1 30.67
  • S2 30.31
  • S3 29.91

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ambalal Sarabhai Ents. has an operating revenue of Rs. 201.60 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 2% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 7% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ambalal Sarabhai Enterprises Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-12 Quarterly Results
2025-08-11 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Ambalal Sarabhai Enterprises Shareholding Pattern

31.36%
0%
0%
0%
58.68%
9.96%

Ambalal Sarabhai Enterprises FAQs

Ambalal Sarabhai Enterprises share price is ₹30 As on 14 May, 2026 | 07:23

The Market Cap of Ambalal Sarabhai Enterprises is ₹236 Cr As on 14 May, 2026 | 07:23

The P/E ratio of Ambalal Sarabhai Enterprises is 21.4 As on 14 May, 2026 | 07:23

The PB ratio of Ambalal Sarabhai Enterprises is 1.6 As on 14 May, 2026 | 07:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23